Press release
Next-Generation Sequencing (NGS) Market to Hit $42.7 Billion by 2031, Growing at 15.7% CAGR
According to this latest publication from Meticulous Research®, the next-generation sequencing (NGS) market is projected to reach $42.7 billion by 2031, at a CAGR of 15.7% during the forecast period. The growth of the NGS market is driven by the rising cancer prevalence & the increasing application of NGS in cancer treatment and research, partnerships between NGS service providers & pharmaceutical companies, technological advancements in NGS, the growing demand for optimized & streamlined NGS workflows, the declining costs of genome sequencing, technological advancements in sequencing procedures, technological advancements in NGS informatics solutions, increasing pharmaceutical R&D expenditures, the surge in genome mapping programs, and improvements in regulatory & reimbursement scenarios for NGS-based diagnostic tests. However, the high costs of NGS systems and consumables, the high costs of automation workstations, data confidentiality concerns, the availability of alternative technologies, the low chances of identifying positive, actionable mutations for precision medicine, and ethical & legal issues related to NGS-based diagnosis restrain the growth of this market.
Download Sample Report Here:
https://www.meticulousresearch.com/download-sample-report/cp_id=5957
Key Players
The key players operating in the next-generation sequencing (NGS) market (Markt für Next-Generation-Sequenzierung (NGS)) are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), MGI Tech Co., Ltd. (China), Tecan Group Ltd. (Switzerland), Beijing Genomics Institute (BGI) (China), Eppendorf AG (Germany), Hamilton Company (U.S.), Hudson Robotics (U.S.), LGC Limited (U.K.), Fabric Genomics, Inc. (U.S.), DNASTAR, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), Novogene Co. Ltd. (China), and Quest Diagnostics Incorporated (U.S.).
Leading Drivers Fueling NGS Market Expansion:
A convergence of powerful factors is driving rapid expansion in the NGS market. Chief among these is the rising prevalence of cancer, which has led to an urgent need for enhanced diagnostics and personalized treatment solutions. NGS is now increasingly adopted in clinical oncology, not only for identifying actionable genetic mutations but also for monitoring disease recurrence through molecular residual disease (MRD) assays-exemplified by new whole-genome sequencing solutions for ctDNA detection recently launched by Illumina Inc. in partnership with Janssen Research & Development. Pharmaceutical companies and NGS service providers have formed strategic partnerships, further speeding adoption of genomic testing in therapeutic development and patient care.
Advancements in sequencing technology and informatics have dramatically improved the speed and accuracy of genome analysis, while declining costs make NGS accessible to a broader range of hospitals, laboratories, and research institutions. The trend toward more optimized and automated workflows-spanning sample preparation, data analysis, and bioinformatics solutions-has reduced turnaround times and increased the efficiency of large-scale projects.
Browse in Depth : https://www.meticulousresearch.com/product/NGS-market-industry-outlook-5957
Technological Trends Shaping the Future:
The future of NGS hinges on several key technological innovations. Comprehensive sequencing platforms, such as sequencing by synthesis and nanopore sequencing, now deliver highly accurate genomic data, minimizing sequence-specific errors and empowering researchers to explore complex regions of the genome. Bioinformatics advancements have enabled secure, efficient data management, allowing seamless sharing and multi-team access to large genomic datasets.
Clinical applications of NGS are expanding, particularly in precision medicine, rare disease diagnosis, and early cancer detection. NGS supports personalized treatment strategies by identifying genetic variability and tailoring interventions to individual patient profiles. Informatics solutions help streamline workflows by automating analysis, monitoring instrument run quality, and transforming raw sequencing data into actionable clinical information.
Furthermore, automation in library preparation, sequencing protocols, and data analysis continues to enhance reliability, reproducibility, and scalability, which are critical for high-throughput research and clinical operations. As large-scale genome mapping programs and collaborative research initiatives proliferate, the adoption of NGS technologies is set to accelerate even further.
Regions Leading Market Growth:
North America currently dominates the NGS market, accounting for 48.7% of the global share in 2024. The region's growth is underpinned by strong R&D investment, proactive government initiatives in genomics, higher awareness of NGS testing, and a favorable reimbursement environment. The U.S.-with its concentration of major market players, cutting-edge research, and robust pharmaceutical sector-remains a powerhouse for NGS adoption and innovation.
However, the Asia-Pacific region stands out for its explosive growth potential, forecasted to experience the highest expansion rate at 16.9% CAGR through 2031.
China and India, in particular, are investing heavily in healthcare infrastructure, genome sequencing programs, and drug discovery, creating significant opportunities for NGS vendors. Government support for biotechnology, affordable skilled workforce, and increasing incidence of genetic diseases and cancer are accelerating market expansion across Asia-Pacific. These trends are gradually shifting the global landscape, with new research hubs and collaborative projects gaining momentum.
Buy the Complete Report with an Impressive Discount: https://www.meticulousresearch.com/view-pricing/1274
Key Questions Answered in the Report:
• Which are the high-growth market segments in terms of offering, application, end user, and region/country?
• What was the historical market size for next-generation sequencing (NGS) products across the globe?
• What are the market forecasts and estimates for 2024-2031?
• What are the major drivers, restraints, opportunities, and challenges in the global next-generation sequencing (NGS) market?
Related Reports:
North America NGS Market: https://www.meticulousresearch.com/product/north-america-ngs-market-5607
Europe NGS Automation Market: https://www.meticulousresearch.com/product/europe-ngs-automation-market-5644
North America NGS Automation Market: https://www.meticulousresearch.com/product/north-america-ngs-automation-market-5736
About Us:
We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with actionable market intelligence tailored to drive revenue transformation and strategic growth. Our insights reveal forward-looking revenue opportunities, providing our clients with a competitive edge through a diverse suite of research solutions-syndicated reports, custom research, and direct analyst engagement.
Each year, we conduct over 300 syndicated studies and manage 60+ consulting engagements across eight key industry sectors and 20+ geographic markets. With a focus on solving the complex challenges facing global business leaders, our research enables informed decision-making that propels sustainable growth and operational excellence. We are dedicated to delivering high-impact solutions that transform business performance and fuel innovation in the competitive global marketplace.
Contact Us:
Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Email- sales@meticulousresearch.com
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Visit Our Website: https://www.meticulousresearch.com/
For Latest Update Follow Us:
LinkedIn- https://www.linkedin.com/company/meticulous-research
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next-Generation Sequencing (NGS) Market to Hit $42.7 Billion by 2031, Growing at 15.7% CAGR here
News-ID: 4174729 • Views: …
More Releases from Meticulous Research®
Nutraceutical Products Market: Growth Trends and Future Outlook to 2030| Meticul …
The nutraceutical products market is witnessing steady and significant growth, driven by a rising awareness of health, nutrition, and disease prevention. Between 2023 and 2030, the market is projected to expand at a compound annual growth rate of 7.8%, ultimately reaching a value of $691.87 billion by the end of the forecast period. This growth reflects a major shift in consumer mindset, as individuals increasingly seek products that offer both…
Global Feed Additives Market Outlook: Trends, Growth Drivers, and Regional Insig …
The way we feed our livestock is changing, and feed additives are at the heart of that transformation. Over the next decade, the global feed additives market is expected to surpass $51 billion, fueled by rising demand for meat and dairy products, concerns over animal health, and a push toward more sustainable farming practice. Farmers today are no longer just feeding animals they are strategically nourishing them to improve growth,…
Global Home Medical Equipment Market: Trends, Insights, and Forecast to 2030 | M …
The home medical equipment market is growing steadily and is projected to reach nearly $63 billion by 2030. These devices are designed to help people manage their health at home, allowing patients to remain independent while receiving the care they need. From respiratory devices to mobility aids, these products make it possible for individuals to maintain a better quality of life without relying entirely on hospital care. They are especially…
Global Membrane Filtration Technologies Market: Trends, Growth Drivers, and Regi …
The membrane filtration technologies market is steadily expanding, with expectations to hit $22.2 billion by 2030. Over the past few years, industries and municipalities alike have faced increasing pressure to manage water more efficiently. Water scarcity, environmental regulations, and operational needs have created a situation where traditional water treatment methods are no longer sufficient. Businesses are turning toward membrane filtration technologies as a solution that offers both reliability and precision.
Water…
More Releases for NGS
Next Generation Sequencing (NGS) : - Key Industry Dynamics
The Next Generation Sequencing (NGS) market size is projected to reach US$ 34.75 billion by 2031 from US$ 10.00 billion in 2023. The market is expected to register a CAGR of 16.8% during 2023-2031. Increased throughput and reduced costs is likely to remain key trends in the market.
Next-generation sequencing (NGS) carries a shift in genomics research, offering unmatched capabilities for analyzing DNA and RNA molecules in a high-throughput and cost-effective…
Next-Generation Sequencing (NGS) Services Next-Generation Sequencing (NGS) Servi …
Global Next-Generation Sequencing (NGS) Services Market Report encompasses market data, such as trends, consumer behavior, and competitive analysis in a way that allows businesses to identify opportunities in the market. The objective of the market research is understood very clearly by DBMR team before the creation of report commences. Intense research takes place to accurately analyze market dynamics and consumer behaviour included in the report.
Global Next-Generation Sequencing (NGS) Services Market,…
Complete PDF Guide to NGS Sample Preparation
The NGS sample preparations determine components in the samples, such as blood, urine, and others, in animals.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 @ https://www.theinsightpartners.com/sample/TIPRE00006573?utm_source=OpenPR&utm_medium=10379
The type of analyzers includes urine analyzers, blood gas & electrolyte analyzers, glucometers, and others used by medical labs, hospitals, and people at home.
Top Companies Analysis -
Agilent Technologies, Inc.
Becton, Dickinson and Company
Beckman Coulter
F. Hoffmann-La Roche AG
Illumina, Inc.
…
NGS Sample Preparation Market - Preparing for Precision: NGS Sample Preparation …
Newark, New Castle, USA: The "NGS Sample Preparation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
NGS Sample Preparation Market: https://www.growthplusreports.com/report/ngs-sample-preparation-market/8504
This latest report researches the industry structure,…
NGS Library Preparation Market - Sequencing Solutions, Redefined: Innovations in …
Newark, New Castle, USA - new report, titled NGS Library Preparation Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the NGS Library Preparation market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global NGS Library Preparation market. The report offers an overview of…
Next Generation Sequencing (NGS) Data Analysis Market Research Report 2020Next G …
The Next Generation Sequencing (NGS) Data Analysis Market report helps identify the biggest opportunities in Next Generation Sequencing (NGS) Data Analysis industry space and offers accurate latent demand forecasting that empowers quantitative decision making among Next Generation Sequencing (NGS) Data Analysis market players and new entrants. Investors will gain a clear insight on the dominant players in Next Generation Sequencing (NGS) Data Analysis industry and their future forecasts. Furthermore, readers…
